Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Notes have priced
Quarterly results
|
|
Clovis Oncology, Inc. (CLVS)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/08/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/08/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/11/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/05/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/13/2020 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/13/2020 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 12/02/2019 |
SC 13G
| HIGHBRIDGE CAPITAL MANAGEMENT LLC reports a 6.5% stake in Clovis Oncology, Inc. |
| 11/15/2019 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 09/27/2019 |
SC 13G
| MORGAN STANLEY reports a 5.8% stake in Clovis Oncology, Inc. |
| 08/20/2019 |
SC 13G
| Elk Creek Partners, LLC reports a 5.2% stake in Clovis Oncology, Inc. |
| 08/19/2019 |
SC 13G
| WHITEBOX ADVISORS LLC reports a 7% stake in Clovis Oncology, Inc. |
| 08/19/2019 |
SC 13G
| D. E. SHAW & CO, L.P. reports a 5% stake in Clovis Oncology, Inc. |
| 08/16/2019 |
SC 13G
| CITADEL ADVISORS LLC reports a 7% stake in Clovis Oncology, Inc. |
| 02/14/2019 |
SC 13G
| Redmile Group, LLC reports a 7.7% stake in Clovis Oncology, Inc. |
| 02/14/2019 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/12/2019 |
SC 13G
| ORBIMED ADVISORS LLC reports a 4.4% stake in Clovis Oncology, Inc. |
| 10/25/2018 |
SC 13G
| Camber Capital Management LLC reports a 6.6% stake in Clovis Oncology, Inc. |
| 06/21/2018 |
SC 13G
| Partner Fund Management, L.P. reports a 7.1% stake in Clovis Oncology, Inc. |
| 02/06/2018 |
SC 13G
| FRANKLIN RESOURCES INC reports a 5.4% stake in Clovis Oncology, Inc. |
| 02/13/2017 |
SC 13G
| Clovis Oncology, Inc. reports a 7.1% stake in Clovis Oncology, Inc. |
| 02/09/2017 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
| 01/11/2017 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
| 07/15/2016 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
| 03/08/2016 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
| 02/10/2016 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
| 03/09/2012 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
| 02/14/2012 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
| 02/10/2012 |
SC 13G
| Versant Side Fund IV, L.P. reports a 10.7% stake in Clovis Oncology, Inc. |
| 12/05/2011 |
SC 13G
| Abingworth LLP reports a 6.3% stake in Clovis Oncology, Inc. |
|
|